Watch Ticker

Compugen Ltd

Go to Compugen Ltd Website

$1.46

0.00 (0.00%)

Live

Previous Close

$1.46

Day Range

$0 - $0

Previous Day Range

$1.44 - $1.48

Market Cap

$136.5 million USD

Day Vol.

0

Previous Day Vol.

79455

Currency

USD

Primary Exchange

Nasdaq

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag

Longboard (LBPH) gains 14% as the FDA grants the Breakthrough Therapy designation to its investigational epilepsy treatment candidate, bexicaserin, for patients aged two years or older.

Related tickers: CGEN, XENE, ALXO, LBPH.

Read Full Article

Zacks Equity Research - FDA Rejects Rocket's (RCKT) Gene Therapy BLA for Rare Disease

Per the FDA, Rocket (RCKT) needs to submit additional manufacturing information on Kresladi gene therapy to secure approval for severe leukocyte adhesion deficiency-I (LAD-I), a rare genetic disorder.

Related tickers: CGEN, HRTX, RCKT, ARQT.

Read Full Article

Trending Tickers

Please sign in to view